These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 25890017)
1. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Pattanaphesaj J; Thavorncharoensap M Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017 [TBL] [Abstract][Full Text] [Related]
2. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population. Kangwanrattanakul K; Parmontree P Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315 [TBL] [Abstract][Full Text] [Related]
3. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
4. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Jia YX; Cui FQ; Li L; Zhang DL; Zhang GM; Wang FZ; Gong XH; Zheng H; Wu ZH; Miao N; Sun XJ; Zhang L; Lv JJ; Yang F Qual Life Res; 2014 Oct; 23(8):2355-63. PubMed ID: 24627090 [TBL] [Abstract][Full Text] [Related]
5. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients. Yu H; Zeng X; Sui M; Liu R; Tan RL; Yang J; Huang W; Luo N Qual Life Res; 2021 Mar; 30(3):855-866. PubMed ID: 32965633 [TBL] [Abstract][Full Text] [Related]
6. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430 [TBL] [Abstract][Full Text] [Related]
7. A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients. Zhang H; Liu B; Gu W; Cao Y; Xu J; Tan RL; Chang E; Zheng W; Li H; Zhou L; Jia Y; Yang H; Guo S; Huang W; Luo N Support Care Cancer; 2023 Dec; 32(1):14. PubMed ID: 38060009 [TBL] [Abstract][Full Text] [Related]
8. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Janssen MF; Pickard AS; Golicki D; Gudex C; Niewada M; Scalone L; Swinburn P; Busschbach J Qual Life Res; 2013 Sep; 22(7):1717-27. PubMed ID: 23184421 [TBL] [Abstract][Full Text] [Related]
9. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia. Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138 [TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Loucks L; Al Khudairy A; Noseworthy TW Qual Life Res; 2015 Jul; 24(7):1775-84. PubMed ID: 25555837 [TBL] [Abstract][Full Text] [Related]
11. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds. van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604 [TBL] [Abstract][Full Text] [Related]
12. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084 [TBL] [Abstract][Full Text] [Related]
13. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788 [TBL] [Abstract][Full Text] [Related]
14. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey. Jankowska A; Młyńczak K; Golicki D Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271 [TBL] [Abstract][Full Text] [Related]
15. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Scalone L; Ciampichini R; Fagiuoli S; Gardini I; Fusco F; Gaeta L; Del Prete A; Cesana G; Mantovani LG Qual Life Res; 2013 Sep; 22(7):1707-16. PubMed ID: 23192232 [TBL] [Abstract][Full Text] [Related]
16. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa. Verstraete J; Amien R; Scott D Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927 [TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Sakthong P; Sonsa-Ardjit N; Sukarnjanaset P; Munpan W Qual Life Res; 2015 Dec; 24(12):3015-22. PubMed ID: 26048348 [TBL] [Abstract][Full Text] [Related]
18. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis. Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the three-level and the five-level versions of the EQ-5D. Christiansen ASJ; Møller MLS; Kronborg C; Haugan KJ; Køber L; Højberg S; Brandes A; Graff C; Diederichsen SZ; Nielsen JB; Krieger D; Holst AG; Svendsen JH Eur J Health Econ; 2021 Jun; 22(4):621-628. PubMed ID: 33733344 [TBL] [Abstract][Full Text] [Related]
20. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population. Shafie AA; Vasan Thakumar A; Lim CJ; Luo N Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]